Dana Investment Advisors Inc. lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 1.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 117,812 shares of the company’s stock after selling 1,575 shares during the quarter. Dana Investment Advisors Inc. owned 0.24% of Prestige Consumer Healthcare worth $8,111,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of PBH. Vanguard Group Inc. raised its position in shares of Prestige Consumer Healthcare by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company’s stock worth $352,391,000 after purchasing an additional 63,375 shares during the period. Ariel Investments LLC raised its holdings in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after buying an additional 274,212 shares during the period. Victory Capital Management Inc. lifted its stake in Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after buying an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Prestige Consumer Healthcare by 26.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after buying an additional 272,773 shares in the last quarter. Finally, Congress Asset Management Co. MA boosted its holdings in shares of Prestige Consumer Healthcare by 12.5% in the first quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock valued at $55,437,000 after buying an additional 84,757 shares during the period. Institutional investors own 99.95% of the company’s stock.
Prestige Consumer Healthcare Stock Up 1.1 %
Shares of PBH stock opened at $72.08 on Tuesday. The firm’s fifty day moving average price is $71.22 and its two-hundred day moving average price is $69.54. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a 1 year low of $56.34 and a 1 year high of $75.80. The firm has a market capitalization of $3.58 billion, a P/E ratio of 17.29, a PEG ratio of 2.01 and a beta of 0.48.
Wall Street Analyst Weigh In
Several research firms recently commented on PBH. DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.20.
View Our Latest Research Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
See Also
- Five stocks we like better than Prestige Consumer Healthcare
- What Does Downgrade Mean in Investing?
- Cloud Growth and AI: DigitalOcean’s Winning Formula Explained
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Brookfield Renewable: Capitalize on the AI and Green Energy Boom
- Do ETFs Pay Dividends? What You Need to Know
- Why Q2 Holdings Stock Could Be Your Next Big Buy
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.